Coverage
-
August 27, 2018
The First Circuit ruled Monday that glaucoma, allergy and other ophthalmic patients in Massachusetts and New York aggrieved by prescription eyedrop bottles that allegedly waste medication cannot sue manufacturers under state laws, affirming the dismissal of the third major class action to challenge eyedropper designs in recent years.
1 other articles on this case.
View all »